MACE, microembolic signals and hs-CRP concentration in CAS group: No death, myocardial infarction, ischemic or hemorrhagic stroke, need of revascularization occurred during the 30-day post-procedural period. This evidence concerns the gene CRP and hemorrhagic stroke.